Correlation Between Israel China and MetLife

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Israel China and MetLife at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Israel China and MetLife into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Israel China Biotechnology and MetLife, you can compare the effects of market volatilities on Israel China and MetLife and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Israel China with a short position of MetLife. Check out your portfolio center. Please also check ongoing floating volatility patterns of Israel China and MetLife.

Diversification Opportunities for Israel China and MetLife

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Israel and MetLife is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Israel China Biotechnology and MetLife in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MetLife and Israel China is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Israel China Biotechnology are associated (or correlated) with MetLife. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MetLife has no effect on the direction of Israel China i.e., Israel China and MetLife go up and down completely randomly.

Pair Corralation between Israel China and MetLife

Assuming the 90 days trading horizon Israel China Biotechnology is expected to generate 27.33 times more return on investment than MetLife. However, Israel China is 27.33 times more volatile than MetLife. It trades about 0.06 of its potential returns per unit of risk. MetLife is currently generating about 0.02 per unit of risk. If you would invest  29,890  in Israel China Biotechnology on December 29, 2023 and sell it today you would earn a total of  92,410  from holding Israel China Biotechnology or generate 309.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy78.79%
ValuesDaily Returns

Israel China Biotechnology  vs.  MetLife

 Performance 
       Timeline  
Israel China Biotech 

Risk-Adjusted Performance

11 of 100

 
Low
 
High
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Israel China Biotechnology are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental drivers, Israel China sustained solid returns over the last few months and may actually be approaching a breakup point.
MetLife 

Risk-Adjusted Performance

13 of 100

 
Low
 
High
Good
Compared to the overall equity markets, risk-adjusted returns on investments in MetLife are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent technical and fundamental indicators, MetLife unveiled solid returns over the last few months and may actually be approaching a breakup point.

Israel China and MetLife Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Israel China and MetLife

The main advantage of trading using opposite Israel China and MetLife positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Israel China position performs unexpectedly, MetLife can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MetLife will offset losses from the drop in MetLife's long position.
The idea behind Israel China Biotechnology and MetLife pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments